Valsartan trial reveals cardiac improvements for patients with early-stage genetic heart condition

Valsartan trial reveals cardiac improvements for patients with early-stage genetic heart condition

Ar andomized, clinical trial of 178 patients with sarcomeric hypertrophic cardiomyopathy found evide...
read more
Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard

Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard

The results of a Phase III randomized clinical tri...
read more
Patients with lung cancer reduce smoking rate after enrollment in phase III clinical trial

Patients with lung cancer reduce smoking rate after enrollment in phase III clinical trial

The first comprehensive, prospective study of smok...
read more
Clinical trial finds vitamin D does not ward off colds and flu

Clinical trial finds vitamin D does not ward off colds and flu

A QIMR Berghofer-led randomized controlled trial o...
read more
Investigational ALS drug pridopidine enters trial

Investigational ALS drug pridopidine enters trial

In 2020, the Sean M. Healey & AMG Center at M...
read more
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ &...
read more
Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH

Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH

FOSTER CITY, Calif. & BAGSVÆRD,&nbs...
read more
Regeneron suspends COVID-19 antibody trial among sickest patients

Regeneron suspends COVID-19 antibody trial among sickest patients

US biotech firm Regeneron on Friday said it was su...
read more
Results from the VOYAGER PAD Trial reported

Results from the VOYAGER PAD Trial reported

A large subgroup analysis of a randomized clinical...
read more
Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine

Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2020&nb...
read more
1 2 3